| Literature DB >> 33171809 |
Yunxia Luan1, Nan Wang1,2, Cheng Li1, Xiaojun Guo1, Anxiang Lu1.
Abstract
Antibiotic abuse is becoming increasingly serious and the potential for harm to human health and the environment has aroused widespread social concern. Aminoglycoside antibiotics (AGs) are broad-spectrum antibiotics that have been widely used in clinical and animal medicine. Consequently, their residues are commonly found in animal-derived food items and the environment. A simple, rapid, and sensitive detection method for on-site screening and detection of AGs is urgently required. In recent years, with the development of molecular detection technology, nucleic acid aptamers have been successfully used as recognition molecules for the identification and detection of AGs in food and the environment. These aptamers have high affinities, selectivities, and specificities, are inexpensive, and can be produced with small batch-to-batch differences. This paper reviews the applications of aptamers for AG detection in colorimetric, fluorescent, chemiluminescent, surface plasmon resonance, and electrochemical sensors for the analysis in food and environmental samples. This study provides useful references for future research.Entities:
Keywords: aminoglycoside antibiotic; antibiotic detection; aptamer; biosensors
Year: 2020 PMID: 33171809 PMCID: PMC7695002 DOI: 10.3390/antibiotics9110787
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Chemical structure of aminoglycoside antibiotics.
Maximum residue limits (MRLs) of some aminoglycosides in various countries.
| Drug Name | Species or Product | Detection Object | MRL (μg kg−1) | |||
|---|---|---|---|---|---|---|
| China | The European Union | The United States | Japan | |||
| Gentamicin | Pig, Cattle | Muscle, Fat | 100 | 50 | 100/400 | 100 |
| Liver | 2000 | 200 | 300 | 2000 | ||
| Kidney | 5000 | 750 | 400 | 5000 | ||
| Milk | 200 | 100 | - | 200 | ||
| Chicken | Tissue | 100 | - | 100 | - | |
| Kanamycin | Cattle | Muscle, Fat | - | 100 | - | 40 |
| Liver | - | 600 | - | 40 | ||
| Kidney | - | 2500 | - | 40 | ||
| Milk | - | 150 | - | 400 | ||
| Pig, Chicken | Muscle | - | 100 | - | 100/50 (chicken) | |
| Fat | - | 100 | - | 100 | ||
| Liver | - | 600 | - | 100/50 (chicken) | ||
| Kidney | - | 2500 | - | 100/500 (chicken) | ||
| Chicken | Egg | - | - | - | 500 | |
| Neomycin | Cattle, Pig, Chicken | Muscle, Fat, Liver | 500 | 500 | 1200/-/3600 | 500 |
| Kidney | 10,000 | 5000 | 7200 | 10,000 | ||
| Milk | 500 | 1500 | 150 | 500 | ||
| Egg | 500 | 500 | - | 500 | ||
| Streptomycin/Dihydrostreptomycin | Cattle, Sheep, Pig | Muscle, Fat, Liver | 600 | 500 | 500 | 600 |
| Kidney | 1000 | 1000 | 2000 | 1000 | ||
| Cattle | Milk | 200 | 200 | - | 200 | |
Specific aptamer sequences of several AGs.
| AGs | Aptamer Sequence (5′–3′) | Ref. | |
|---|---|---|---|
| Kanamycin | TGGGGGTTGAGGCTAAGCCGA | 0.079 | [ |
| Neomycin B | GGCCUGGGCGAGAAGUUUAGGCC | 1.24 | [ |
| Streptomycin | TAGGGAATTCGTCGACGGATCCGGGGTCTGGTGTTCTGCTTTGTTCTGTCGGGTCGTCTGCAGGTCGACGCATGCGCCG | 0.199 | [ |
| Tobramycin | GACTAGGCACTAGTC | 0.042 | [ |
Summary of aptasensor types, detection methods, and performances.
| Sensor Type | Method | Strategy | Analytes | LOD* | Ref.* |
|---|---|---|---|---|---|
| Colorimetric | NaCl-AuNPs | High-salt induce AuNPs* aggregation from red to blue | Kanamycin | 25 nmol/L | [ |
| the catalytic chromogenic reaction of AuNPs mimics enzymes | Streptomycin | 86 nmol/L | [ | ||
| NaCl-AgNPs | based on analyte-protected and aptamer-selective mechanism | Kanamycin | 2.6 ng/mL | [ | |
| Fluorescent | Labeled | labeled with Exo III, AuNPs and FAM*. | Kanamycin | 321 pmol/L | [ |
| Poly A and FAM modified at the two ends of aptamer | Neomycin B | 0.01 μmol/L | [ | ||
| A fluorescent “signal-on” switch aptasensor based on QDs-SSB* | Streptomycin | 0.03 ng/mL | [ | ||
| The fluorescence resonant energy transfer based on UCNPs* and graphene oxide (GO) | Kanamycin | 9 pmol/L | [ | ||
| Non-labeled | digestion of dsDNA by ExoIII and the ability of SYBR Gold as a fluorescent dye | Streptomycin | 54.5 nmol/L | [ | |
| dsDNA-capped mesoporous silica nanoparticles and Rhodamine B | Kanamycin | 7.5 nmol/L | [ | ||
| Chemiluminescence | Cold light probe | The Pt complex performs signal transduction | Kanamycin | 143 nmol/L | [ |
| FALIA* assay | CNP*-aptasensor probe | Kanamycin | 5 × 10−8 ng/mL | [ | |
| Surface plasmon resonance | Competitive effect | RNA aptamer modified by methyl groups | Neomycin B | 5 nmol/L | [ |
| Electrochemical | Differential pulse voltammetry (DPV) | GR* and AuNPs modified on glassy carbon electrode surface as adaptor carriers | Kanamycin Streptomycin | 0.03 pmol/L | [ |
| conductive polymer/gold self-assembled nanocomposite | Kanamycin | 9.4 ± 0.4 nmol/L | [ | ||
| Square wave voltammetry (SWV) | The background signal compressed by exonuclease | Kanamycin | 1 pmol/L | [ | |
| nanoscale metal organic framework | Kanamycin | 0.16 pmol/L | [ | ||
| Alternating current voltammetry (ACV) | Target induces signal probe transfer | Kanamycin | 3.3 pmol/L | [ | |
| Electrochemical impedance spectroscopy (EIS) | screen printing carbon electrode | Kanamycin | 0.11 ng/mL | [ | |
| protein-oriented carbon nanoparticles embedded with SnOx and TiO2 nanocrystalline | Tobramycin | 6.7 pg mL−1 | [ |
* Limit of detection(LOD), references (Ref.), Gold nanoparticles (AuNPs), fluorescein amidite(FAM), a single stranded DNA binding protein on quantum dots (QDs-SSB), upconversion nanoparticles (UCNPs), fluorescence-based aptamer-linked immunosorbent assay(FALIA), carbon nanoparticles(CNP), Graphene(GR).
Figure 2Schematic illustration of the AuNP-based colorimetric assay for detection of kanamycin [59].
Figure 3Schematic illustration of a fluorescent aptasensor. (A) A fluorescent “on” switch aptasensor containing QDs-SSB [69]. (B) Fluorescence resonance energy transfer between kanamycin aptamer UCNPs and graphene [70]. (C) Unlabeled fluorescence analysis [71]. (D) dsDNA-modified mesoporous silicon nanoparticles (MSNs) loaded with rhodamine B [72].
Figure 4Schematic illustration of a chemiluminescent aptasensor. (A) A luminescent probe containing an aptamer and Pt(II) [73]. (B) A carbon nanoparticles aptasensor [74].
Figure 5Schematic illustration of an electrochemical aptasensor. (A) Conductive polymer/gold self-assembled nanocomposite [76]. (B) Aptamer–metal ion nanoscale metal organic framework (MOF) electrochemical biocodes for detection of multiple antibiotics [78]. (C) The target-induced signal probe transfer mechanism [79]. (D) Preparation of BSA-directed SnO@TiO2@mC nanocomposites and application to tobramycin detection [81].